Home / Pharmaceutical / Medical Biosensors Market By Technology Type (Optical Medical Biosensors, Electrochemical Medical Biosensors, Piezoelectric Medical Biosensors, Thermal Medical Biosensors, Nanomechanical Medical Biosensors), By Application (Cardiac Care, Home Diagnostics, Pain Management, Drug Discovery, Genomics, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Medical Biosensors Market By Technology Type (Optical Medical Biosensors, Electrochemical Medical Biosensors, Piezoelectric Medical Biosensors, Thermal Medical Biosensors, Nanomechanical Medical Biosensors), By Application (Cardiac Care, Home Diagnostics, Pain Management, Drug Discovery, Genomics, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Published: Oct 2018 | Published By: Acute Market Reports

"New technology assessment in the medical biosensors market to exhibit significant growth during the forecast period"

The global Medical biosensors market is growing productively, was valued at US$ 9.2 Bn in 2017 and expected to reach US$ XX Bn by 2026. New technology assessment in the biological and electronic component of a biosensor in the portable devices is enhancing the overall growth significantly. Advancement in point-of-care testing, environmental monitoring and nanotechnology shows promising growth in near future. High prevalence of chronic diseases along with diabetes, cardiovascular and cancer provides major opportunity in the global market. Blood glucose monitoring medical biosensors play a vital role in the global market, growing diabetic population in the urban areas is enhancing the demand for blood glucose monitoring biosensors. Biosensor applications are boosting the demand in medical diagnostic field mainly, cholesterol monitoring, pregnancy testing, and drug discovery. For instance, as indicated by International Diabetes Federation statistics, the diabetic population is projected to influence more than 550 million people in 2030.

Moreover, the demand for portable and user friendly devices is gaining traction in the home healthcare diagnostics segment.  Major factors driving the global demand of medical biosensors include, increasing popularity in the personalized medicine segment, higher inclination towards non-invasive medical biosensors, new product launches in the wearable medical biosensors industry, and wide usage of applications in the home diagnostics (blood glucose monitor, blood pressure, cholesterol, lead), genomics industry (clinical microsensor arrays), research laboratories, pain management and imaging operations. Factors restraining the market growth include stringent regulatory environment in the developed nations, safety & security concerns in home care and point of care. Moreover, low awareness, less or no investment in R&D, and unmet need in the developing countries is restraining the overall growth of the market.

"Electrochemical technology type segment is expected to register higher growth by the end of 2026"

In 2017, electrochemical biosensors holds maximum market share, have greater advantages over thermal or optical detection. The penetration is high in the applications segment due to its higher stability, low limits of detection and wide response range.

Wearable biosensors show promising growth during the forecast period. Rising prevalence for diabetes and cardiovascular diseases along with demand for instant diagnostics globally is generating maximum revenue share. Other major factors driving the growth include development of nanotechnology-based medical biosensors, high demand for point-of-care devices, and public funding for development of genomics and proteomics. Additionally, increasing population with chronic diseases and launch of new medical biosensors in the optical and electrochemical technology segment is driving the growth of the market.

"Medical diagnostics segment dominated the market with a significant CAGR"

Growth & development of the medical biosensors in the medical field is gaining traction during the forecast period. The medical diagnostics application section includes high usage of medical biosensors in the field of blood glucose monitoring, cholesterol testing, blood gas analyzer, drug discovery, pregnancy testing, and various infectious diseases. Medical biosensors are now considered as an important tool in the monitoring and detection of a wide range of medical or therapeutic conditions, majorly diabetes and cancer.

The rise in usage of biosensor technology in cardiac care and homecare testing is generating significant revenue share. A noteworthy development in the drug delivery applications (transdermal/iontophoresis), administrations of medical biosensors in lab on chip, biochip, clinical proteomics and advanced usage of medical biosensors for pain free diagnostics show significant growth in the market. Other major applications include high usage of blood glucose monitoring in the home care settings is also generating maximum revenue share in the global, market.

"Increasing applications along with new technology launch, presence of top players holds North America in dominant position"

In 2017, North America contributed maximum revenue share in the global medical biosensors market attributed to the rising technology advancement in the field of microelectronics and biotechnology. Increasing market penetration of electronic medical records, growing patient awareness levels, enhanced applications in the cardiac care and point of care segment is further going to spur revenue growth in the North America region.

Major external factors contributing to the growth include increasing R&D in the genomics segment, nanotechnology, increasing adoption of personalized technologically advanced products and expansion of miniaturized diagnostic equipment in developing economies is increasing significantly. Nevertheless, in low economic countries such as South Africa, China, India, Brazil, and others, the accessibility of advanced equipment and facilities is inadequate. Less investment in R&D, unwillingness toward the implementation of latest treatment models, slow rate of exploitation and low awareness are few factors restraining the growth of the market. Increasing development of disposable biosensors by small or medium sized manufacturers in the Asia Pacific region and shifting interest towards home care is gaining traction in the global market.

"Presence of multinational manufacturers with strong technology type portfolio in the developed regions"

Top manufacturers in the medical biosensors market are Pinnacle Technology, Inc., Polestar Technologies Inc., Eastprint Incorporated, DuPont Biosensor Materials, Medical biosensors International Group, Ltd., Surfix BV, World Precision Instruments, Inc., Ercon, Inc., ACON Laboratories, Inc., Siemens Healthcare Diagnostics Inc., Innovative Medical biosensors, Inc., EG & IC Sensors, Inc., Molecular Devices, LLC., Abbott Laboratories, Inc., Nova Biomedical Corporation, ACCESS BIO, INC., Silicon Kinetics, Bio-Rad Laboratories, Inc. and others. Small companies are implementing progressive approaches along with new technology expansion in new medical biosensors models in medical diagnostics, drug discovery and research laboratories. For example, in July 2018, Nanomedical Diagnostics launched new graphene biosensor named Super Amine-Immobilization Biosensor – SCOOH to further accelerate the drug discovery development. Also in Dec 2017, MediaTek launched the new Sensio MT6381 biosensor. For instance, in Nov 2016 Dreamtech and Hmicro (now LifeSignals) came into a partnership agreement to develop and manufacture biosensor patches and related wireless receivers.

Historical & Forecast Period

This study report represents analysis for each segment from 2016 to 2026 considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

 

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Billion
Segmentation

 Technology Type (2016–2026; US$ Bn)
 • Optical Medical biosensors
 • Electrochemical Medical biosensors
 • Piezoelectric Medical biosensors
 • Thermal Medical biosensors
 • Nanomechanical Medical biosensors

 Application Segment (2016–2026; US$ Bn)
 • Cardiac Care
 • Home Diagnostics
 • Pain Management
 • Drug Discovery
 • Genomics
 • Others (Infectious Disease Testing, Biomarkers, Microfluids)

 Geography Segment (2016–2026; US$ Bn)
 • North America (United States and Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall medical biosensors market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, technology type portfolio and business strengths.

Key questions answered in this report

  • What are the current market trends and dynamics in the medical biosensors market and valuable opportunities for emerging players?
  • Market positioning of major key players operating in the market?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which technology type holds a larger market share and why?
  • What is the impact of high cost in the medical biosensors market?
  • Are low and middle-income economies investing in the Medical biosensors market?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?

TABLE 1 Market Snapshot: Global Medical Biosensors (MB) Market
TABLE 2 Global MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 3 Global MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 4 Global MB Market, by Geography, 2016–2026 (US$ Mn)
TABLE 5 North America MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 6 North America MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 7 North America MB Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 9 Europe MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 10 Europe MB Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 11 Latin America MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 12 Latin America MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 13 Latin America MB Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Asia Pacific MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 15 Asia Pacific MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 16 Asia Pacific MB Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 17 Middle East & Africa MB Market, by Technology Type, 2016–2026 (US$ Mn)
TABLE 18 Middle East & Africa MB Market, by Application, 2016–2026 (US$ Mn)
TABLE 19 Middle East & Africa MB Market, by Region, 2016–2026 (US$ Mn)
TABLE 20 Biosensors International Group, Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 Pinnacle Technology, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 Polestar Technologies Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 Eastprint Incorporated: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 DuPont Biosensor Materials: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Surfix BV: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 World Precision Instruments, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 EG & IC Sensors, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Ercon, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 ACON Laboratories, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Molecular Devices, LLC.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Abbott Laboratories, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Nova Biomedical Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 ACCESS BIO, INC.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Silicon Kinetics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Bio-Rad Laboratories, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 Siemens Healthcare Diagnostics Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Innovative Biosensors, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +